Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 21Rectal Neoplasms 10Colonic Neoplasms 6Pancreatic Neoplasms 4Stomach Neoplasms 3Neoplasm Metastasis 3Adenocarcinoma Of Esophagus 3Peritoneal Neoplasms 2Neoplasms 2Liver Neoplasms 2Esophageal Neoplasms 2Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Neuropathy, Painful 1Neuralgia 1Neoplasm Recurrence, Local 1Malignant Solid Tumour 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Disease Progression 1Cold Hypersensitivity 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Carcinoma, Basal Cell 1Breast Neoplasms 1Bile Duct Neoplasms 1Advanced Rectal Cancer 1Advanced Primary Liver Cancer 1Adenocarcinoma of the Lower Rectum 1

Interventions

Sorafenib 52pembrolizumab 26Nivolumab 20Bevacizumab 19Radiosurgery 17Doxorubicin 12atezolizumab 9Erlotinib Hydrochloride 9lenvatinib 8cabozantinib 7Magnetic Resonance Spectroscopy 7tremelimumab 6durvalumab 6Ramucirumab 6Radiofrequency Ablation 6Cisplatin 6Sunitinib 5tislelizumab 4regorafenib 4Oxaliplatin 4Leucovorin 4Ipilimumab 4Fluorouracil 4Everolimus 4Capecitabine 4nintedanib 3fluoromisonidazole 3carotuximab 3bavituximab 3Tomography, X-Ray Computed 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Hepatocellular × Folfox protocol × Clear all
NCT02069041 2018-11-21

A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer

Eli Lilly and Company

Phase 1 Completed
8 enrolled 16 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡